Phase 2 N=20 Treatment

Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania

Trichotillomania

Bottom Line

View on ClinicalTrials.gov: NCT01654523 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2016

Primary outcome: Primary: Mean Change in Massachusetts General Hospital Hairpulling Scale Baseline to Post-treatment — 6.695 Units on a scale — p=<0.05

Study Design & Population

Study type: Interventional
Phase: Phase 2
Interventions: Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania (Device)
Age: Adult · 18+ yrs
Sex: All
Sponsor: University of Michigan
Primary completion: Jun 2014

Outcome Measures

Outcome	Result	p-value
PRIMARY Mean Change in Massachusetts General Hospital Hairpulling Scale Baseline to Post-treatment	6.695	<0.05 sig

Summary

The goals of the study are to further design, develop, and test an awareness enhancement and monitoring device, which will be used in the self-awareness training and general treatment of patients with compulsive hair-pulling behaviors, or trichotillomania.

Eligibility Criteria

Inclusion Criteria

Must have active hair pulling over the month prior to enrollment
Must have noticeable hair loss
Must experience significant distress related to Trichotillomania
Must primarily pull from the head area
Subjects taking medications will be included
Must be able to read/write English

Exclusion Criteria

Current substance use diagnosis
Chronic neurological disorder (other than chronic tics)
Mental retardation
Schizophrenia and other psychotic disorders
Bipolar I disorder
Prominent suicidal/homicidal ideation with imminent risk

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01654523). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.